Keyphrases
Dosing Time
72%
Linezolid
64%
Pharmacokinetics
46%
Docetaxel
44%
Population Pharmacokinetics
41%
Rheumatoid Arthritis
40%
Adriamycin
39%
Plasmid DNA (pDNA)
33%
Methotrexate
29%
Cisplatin
29%
Thrombocytopenia
28%
Dosing Schedule
27%
Polyethylenimine
26%
Antitumor Effect
24%
Chronotherapy
23%
24-h Rhythm
23%
Cardiotoxicity
23%
Cisplatin-induced
21%
Tumor Necrosis Factor-α
19%
Hospitalized Patients
19%
Gene Expression
19%
Time Dependency
19%
Renal Function
16%
NONMEM
15%
Arthritis
15%
Therapeutic Index
15%
Circadian Rhythm
15%
DOTMA
15%
Renal Disease
14%
Gene Delivery
14%
Chronopharmacology
14%
Collagen-induced Arthritis Rat
14%
Mouse Model
14%
Adverse Effects
14%
Circadian Clock
13%
Clinical Efficacy
13%
Cyclosporine
13%
Hybrid Vector
12%
Toxicity Effects
12%
Mizoribine
12%
Teicoplanin
12%
Drug Interactions
12%
Hepatitis
12%
Brainstem
12%
Opioid Receptor Expression
12%
Cardioprotection
12%
Ternary Complex
12%
Benzalkonium Chloride
12%
Transepithelial Electrical Resistance
12%
Dark Phase
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Linezolid
64%
Docetaxel
44%
Doxorubicin
44%
Cisplatin
35%
Rheumatoid Arthritis
31%
Inflammatory Arthritis
31%
Thrombocytopenia
28%
Methotrexate
28%
Gene Delivery
28%
Pharmacodynamics
26%
Cardiotoxicity
26%
Plasmid DNA
24%
Chronotherapy
22%
Neoplasm
21%
Adverse Event
19%
Polyethyleneimine
17%
Glucocorticoid
15%
Therapeutic Window
15%
Nephrotoxicity
14%
Chronopharmacology
14%
Mouse Model
13%
Collagen-Induced Arthritis
13%
Ciclosporin
13%
Murine Hepatitis
12%
Drug-Drug Interaction
12%
Mizoribine
12%
Teicoplanin
12%
Opiate Receptor
12%
Cytotoxicity
12%
Methicillin-Resistant Staphylococcus Aureus
12%
Chemotherapy
11%
Arthritis
11%
Morphine
11%
Messenger RNA
10%
Cytokine
10%
Analgesic Agent
10%
Daptomycin
9%
Mycophenolic Acid
9%
Tumor Growth
9%
Neuropathy
9%
C Reactive Protein
9%
Sodium Valproate
9%
Phenobarbital
9%
Lipoplex
9%
Benzalkonium Chloride
8%
Pharmacokinetic Parameter
8%
Liposome
8%
Mechanical Allodynia
8%
Lipopolysaccharide
8%